FAK inhibitor and RAF/MEK clamp avutometinib enhance KRAS G12C inhibitor efficacy in preclinical models of non-small cell lung cancer. (science.org)

Authors: Coma S … Pachter JA Journal: Science Translational Medicine Published: 2026-09-30 DOI: https://doi.org/10.1126/scitranslmed.aea4608